DYN
Dyne Therapeutics Inc
NASDAQ: DYN · HEALTHCARE · BIOTECHNOLOGY
$17.41
-4.13% today
Updated 2026-04-29
Market cap
$2.88B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$8 – $25
Volume
2.2M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$38.19
+119.36%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy11 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-112.32M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-165.24M | $-235.94M | $-317.42M | $-446.21M | $-111.95M |
| EPS | — | — | — | — | $-3.47 |
| Free cash flow | $-156.71M | $-188.89M | $-294.75M | $-405.13M | $-112.32M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Dyne Therapeutics Inc trades at $17.41. Our Smart Value Score of 37/100 indicates the stock is weak.
Frequently asked questions
What is Dyne Therapeutics Inc's stock price?
Dyne Therapeutics Inc (DYN) trades at $17.41.
Is Dyne Therapeutics Inc overvalued?
Smart Value Score 37/100 (Grade D, Sell).
What is the price target of Dyne Therapeutics Inc (DYN)?
The analyst target price is $38.19, representing +119.4% upside from the current price of $17.41.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-55.70%
Beta1.29
50D MA$17.73
200D MA$16.43
Shares out0.17B
Float0.16B
Short ratio—
Avg volume2.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—